NSE filing, NSE: CYIENTDLM. Summary written from the filing by ALFA Finder's alert engine.
Cyient DLM Ltd: key numbers
- Share price
- ₹763.30
- Market cap
- ₹6,059 Cr
- Revenue (annual)
- ₹1,261 Cr
- Net profit (annual)
- ₹73.28 Cr
- P/E (TTM)
- 72.2×Sector 43.1×
- Promoter holding
- 52.11%+0.00% QoQ
- FII holding
- 2.43%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Cyient DLM Ltd
All →Cyient DLM Management Change
Cyient DLM Limited has appointed Mr. Sandip Mishra as Senior Vice President & Chief Human Resources Officer. He joins with over 29 years of global experience in HR leadership.
Cyient DLM Employee Stock Options
Cyient DLM Limited has granted 10,000 stock units under its RSU Scheme 2023. Additionally, 2,63,400 options were granted under the ASOP Scheme 2023 to company associates.
Cyient DLM Earnings Call Transcript: Key Takeaways
Cyient DLM delivered strong 26.5% YoY revenue growth, but EBITDA margins contracted to 8.7% due to aggressive front-ended investments in sales and product development.
Cyient DLM Board Meeting Outcome
Cyient DLM Limited announced the reconstitution of its Corporate Social Responsibility (CSR) committee, effective 15 October 2026. The committee members were updated accordingly.
Cyient DLM Other Announcement
Cyient DLM Ltd has submitted its quarterly shareholding pattern as per Regulation 31(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Cyient DLM Board Meeting Date
Cyient DLM Limited has scheduled a board meeting for October 15, 2026. The board will consider and approve unaudited financial results for the September 2026 quarter.
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.